# Skeptic's Critique: Mechanistically Novel Hypotheses for Novel ALS Genes
---
## Hypothesis 1: MATR3 → MICOS Complex Integrity
### Strongest Weakness: Assumed Direct Anchoring Role is Unproven
The hypothesis claims MATR3 "anchors" the MICOS complex through MIC60/IMMT at the inner mitochondrial membrane, but this mechanistic claim lacks direct biochemical support. MATR3 is primarily characterized as a nuclear matrix protein involved in RNA processing and nuclear organization. The cited interaction (PMID: 27816900) may demonstrate *some* mitochondrial association, but does not establish that MATR3 physically scaffolds MICOS components or regulates cristae junction stability. Correlation of mitochondrial localization does not equal mechanistic causality.
### Counter-Evidence and Complications
1. **Alternative MATR3 pathogenic mechanisms**: Pathogenic MATR3 variants (e.g., S85C, P154S) are also associated with myopathy and vocal cord paralysis. If mitochondrial cristae disruption were the primary driver, muscle pathology patterns would be expected to mirror classic mitochondrial myopathies more closely. Nuclear envelope dysfunction and RNA splicing defects remain viable—and perhaps dominant—alternative mechanisms (e.g., Senderek et al., *Neurology*, 2013).
2. **MICOS phenotypes are typically more severe**: Complete loss of MIC60/IMMT is embryonic lethal or causes rapid multi-organ failure in mice. MATR3 mutations cause late-onset, relatively selective motor neuron disease. This suggests MATR3's role (if mitochondrial at all) is either more subtle or non-essential to core MICOS function.
3. **Patient iPSC data not aligned**: If cristae remodeling were the core defect, one would expect more consistent metabolic phenotypes across patient lines. Reported phenotypes in MATR3 patient lines are heterogeneous.
### Pointed Question
**What is the direct biochemical evidence that MATR3 physically interacts with MIC60 or other core MICOS components in mitochondria, and can you demonstrate that ALS-associated MATR3 mutations disrupt this interaction specifically—rather than MATR3 being a bystander in mitochondrial fractions from nuclear contamination?**
### Confidence Rating: **Weak → Moderate**
The hypothesis is mechanistically creative and fits with CHCHD10 comparisons, but rests on an unproven direct interaction claim. The connection to MICOS is inferential. Without demonstrating that MATR3 mutations directly destabilize MICOS in patient-derived cells, this remains a plausible but unvalidated model. The "motor neuron selectivity" claim also needs explanation beyond "high metabolic demand"—why aren't other high-energy cells equally affected?
---
## Hypothesis 2: TUBA4A → TBK1 Axonal Transport ("Two-Hit")
### Strongest Weakness: The "Two-Hit" Model Creates Mechanistic Confusion
The two-hit framing implies TUBA4A mutations *alone* cause disease by impairing TBK1 transport, but this collapses when considering TBK1 itself is an independent ALS gene. If TBK1 dysfunction were the primary output, *TB